Vladimir Lazar Selected Research

Vladimir Lazar Research Topics

Disease

52	Neoplasms (Cancer) 01/2023 - 08/2004
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 07/2007
6	Breast Neoplasms (Breast Cancer) 11/2016 - 01/2009
5	Melanoma (Melanoma, Malignant) 04/2013 - 04/2006
4	Carcinogenesis 09/2011 - 07/2005
4	Tetraploidy 07/2010 - 06/2006
3	Lung Neoplasms (Lung Cancer) 01/2023 - 08/2012
3	Glioma (Gliomas) 01/2012 - 01/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2014
2	Neoplasm Metastasis (Metastasis) 11/2016 - 05/2015
2	Triple Negative Breast Neoplasms 11/2016 - 06/2014
2	Genomic Instability 09/2011 - 07/2010
2	Burkitt Lymphoma (Burkitt's Lymphoma) 09/2009 - 02/2005
2	Infections 03/2004 - 10/2003
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Pathologic Neovascularization 11/2016
1	Hypoxia (Hypoxemia) 11/2014
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 11/2014
1	Acute Promyelocytic Leukemia 10/2013
1	Sarcoma (Soft Tissue Sarcoma) 05/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2013
1	Supratentorial Neoplasms 01/2012
1	Diffuse Intrinsic Pontine Glioma 01/2012
1	Brain Neoplasms (Brain Tumor) 01/2012
1	Starvation 12/2011
1	Thrombocytopenia (Thrombopenia) 02/2011
1	Leukemia 02/2011
1	Ependymoma 09/2010

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2016 - 10/2003
9	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 06/2006
9	Biomarkers (Surrogate Marker)IBA 11/2016 - 05/2010
6	MicroRNAs (MicroRNA)IBA 06/2015 - 03/2010
6	Cisplatin (Platino)FDA LinkGeneric 09/2012 - 06/2006
4	OligonucleotidesIBA 09/2009 - 07/2005
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2008
3	ParaffinIBA 01/2019 - 09/2011
3	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2007
3	Cadherins (E-Cadherin)IBA 07/2014 - 03/2007
2	LigandsIBA 01/2023 - 01/2019
2	CytokinesIBA 01/2022 - 07/2014
2	Axitinib (AG 013736)IBA 01/2022 - 04/2021
2	Nucleic AcidsIBA 04/2020 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 11/2016 - 10/2009
2	Transcription Factors (Transcription Factor)IBA 02/2011 - 03/2004
1	Calcibiotic Root Canal SealerIBA 01/2023
1	palbociclibIBA 01/2022
1	avelumabIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	pembrolizumabIBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	Everolimus FDA Link 04/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2020
1	ProdrugsIBA 04/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2020
1	Glutamine (L-Glutamine)FDA Link 04/2020
1	Natural Cytotoxicity Triggering Receptor 2IBA 01/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2019
1	Natural Killer Cell ReceptorsIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 11/2016
1	Progesterone FDA LinkGeneric 11/2016
1	Semaphorins (Semaphorin)IBA 11/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015
1	Bevacizumab (Avastin)FDA Link 04/2015
1	Checkpoint Kinase 1IBA 06/2014
1	Dacarbazine (DIC)FDA LinkGeneric 04/2014
1	Sorafenib (BAY 43-9006)FDA Link 04/2014
1	Kazal Pancreatic Trypsin InhibitorIBA 12/2013
1	sorbitan monolaurateIBA 10/2013
1	ArsenicIBA 10/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2013
1	Retinoic Acid Receptor alphaIBA 10/2013
1	Trastuzumab (Herceptin)FDA Link 10/2013
1	Cathepsin DIBA 09/2013
1	AVE1642IBA 05/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	CarcinogensIBA 09/2012
1	CalreticulinIBA 09/2012
1	Cadmium Chloride (Cadmium Dichloride)IBA 09/2012
1	N-acetylsphingosineIBA 09/2012
1	Vitamin B 6IBA 08/2012
1	Glutathione (Reduced Glutathione)IBA 08/2012
1	Cytotoxins (Cytolysins)IBA 08/2012
1	InterferonsIBA 03/2012
1	dipinacoline glutamateIBA 01/2012
1	MyoD ProteinIBA 12/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2010
1	Indicators and Reagents (Reagents)IBA 10/2010
1	brivanibIBA 10/2010
1	hydrogen sulfite (bisulfite)IBA 09/2010

Therapy/Procedure

14	Therapeutics 01/2023 - 01/2007
3	Precision Medicine 01/2019 - 01/2011
3	Drug Therapy (Chemotherapy) 09/2011 - 12/2007
2	Immunotherapy 01/2021 - 07/2008
2	Aftercare (After-Treatment) 01/2013 - 03/2007
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2020
1	Intravenous Administration 01/2019
1	Adjuvant Chemotherapy 09/2016